Indian pharmacy Oncohiv aims to play a key role in supporting the nation’s healthcare system.
Generic medicines are typically 80% to 85% cheaper than their brand-name equivalents, saving money.
Oncohiv is a mass distributor of generic drugs and OTC healthcare products since 2011. It has been providing quality service and cheaper generic medicines to consumers across the globe.
In India, generic medicines have an integral role in supporting the public healthcare system, according to The Asian Age. The nation is home to a significant amount of poor population who cannot afford brand-name medicines. Therefore, generic drugs can significantly reduce the cost, making public healthcare more affordable.
Global drug regulatory bodies say generic drugs are not different from their branded counterpart in terms of indications, dosage, route of administration, and quality. The only major difference is the price.
In addition, the Indian government has taken several regulatory steps to popularize the use of generics in India, per The Asian Age. For instance, in 2008, the government teamed up with the Department of Pharmaceuticals to start a new initiative called “Jan Aushadhi.”
The Medical Council of India has also been promoting the use of generic drugs by recommending physicians to prescribe drugs with generic names.
Oncohiv is also following the same vision by supplying safe and affordable generic drugs online, making healthcare accessible to the people of India.
Oncohiv specifically deals with a wide range of generic drugs for cancers, including blood cancer, brain cancer, breast cancer, liver cancer, leukemia, prostate cancer, skin cancer, and thyroid cancer. It also distributes generic medicines for Hepatitis B, Hepatitis C, Hodgkin’s Disease, and HIV/ AIDS.
To tackle the ongoing COVID-19 pandemic, Oncohiv has been supplying generic versions of ivermectin, hydroxychloroquine, and favipiravir. The online drugstore also deals with life-saving malaria drugs like Falcigo, an antiparasitic medication that contains artesunate.
Oncohiv follows strict regulatory measures to match the international standards. It has a dedicated Quality Audit Team that regularly works to monitor all generic drugs and orders to ensure the best services and experiences for all of its consumers.
All generic drugs and OTC products offered by Oncohiv are developed in the World Health Organization (WHO) approved facilities, testifying the safety and efficacy of medicines. The Indian government is trying to rebuild its healthcare infrastructure and Oncohiv foresees to aid the government’s efforts by delivering generic drugs and OTC products in the nation.